Related Experiment Videos
THC does not affect striatal dopamine release: microdialysis in freely moving rats
E Castañeda1, D E Moss, S D Oddie
1Department of Psychology, University of Lethbridge, Alberta, Canada.
Pharmacology, Biochemistry, and Behavior
|November 1, 1991
Summary
Tetrahydrocannabinol (THC) does not affect dopamine levels or the motor effects of antipsychotics. This study found no evidence that cannabinoids stimulate dopaminergic activity or contribute to drug abuse potential.
Area of Science:
- Neuroscience
- Pharmacology
- Neurochemistry
Background:
- Cannabinoids are hypothesized to potentiate neuroleptic motor effects and possess abuse potential via dopaminergic stimulation.
- Understanding the interaction between cannabinoids and the dopaminergic system is crucial for psychiatric and addiction research.
Purpose of the Study:
- To investigate whether tetrahydrocannabinol (THC) increases extracellular dopamine concentrations.
- To determine if THC modulates the dopaminergic response to amphetamine and fluphenazine.
Main Methods:
- Male Long-Evans rats were used, with cannulae implanted in the striatum or nucleus accumbens.
- Microdialysis was employed to measure extracellular concentrations of dopamine (DA), DOPAC, HVA, and 5-HIAA.
- Rats received THC (1.0 or 10 mg/kg) or vehicle, followed by amphetamine or fluphenazine.
Main Results:
- THC administration did not alter extracellular concentrations of DA, DOPAC, HVA, or 5-HIAA.
- THC did not affect the increase in extracellular DA induced by amphetamine.
- THC did not influence the transient increase in DA, DOPAC, and HVA caused by fluphenazine.
Conclusions:
- The study found no evidence to support the hypothesis that cannabinoids stimulate dopaminergic activity.
- THC did not potentiate the motor effects of neuroleptics or influence amphetamine-induced dopamine release.
- These findings suggest cannabinoids may not contribute to abuse potential through direct dopaminergic stimulation.